These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7040013)

  • 21. [Dynamic aspects of the renin-plasma activity in subjects affected by essential arterial hypertension].
    Gragnoli G; Tanganelli I; Palazzuoli V
    Boll Soc Ital Cardiol; 1974; 19(3):313-21. PubMed ID: 4377408
    [No Abstract]   [Full Text] [Related]  

  • 22. [The fole of the renin-angiotensin system in secondary aldosteronism (author's transl)].
    Kondo K
    Nihon Naika Gakkai Zasshi; 1975 Jan; 64(1):23-32. PubMed ID: 1236910
    [No Abstract]   [Full Text] [Related]  

  • 23. [Studies on effects of renin-angiotensin system on hemodynamics and cardiovascular system in essential hypertension (author's transl)].
    Kimura M; Ishimaru K
    Nihon Jinzo Gakkai Shi; 1980 Nov; 22(11):1447-62. PubMed ID: 7009936
    [No Abstract]   [Full Text] [Related]  

  • 24. Increased adrenal sensitivity to angiotensin II in low-renin essential hypertension.
    Wisgerhof M; Brown RD
    J Clin Invest; 1978 Jun; 61(6):1456-62. PubMed ID: 659608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hormone profile of the essential hypertension patient with ischemic cardiopathy. I. Renin, angiotensin and aldosterone].
    Villalpando Gutiérrez J; Hernández y Hernández H; Soto de la Torre JL; Villalpando Hernández S; Exaire Murad E; Arévila Ceballos N; Urquieta Aguila B
    Arch Inst Cardiol Mex; 1983; 53(2):99-104. PubMed ID: 6349565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical usefulness of saralasin in human hypertension (author's transl)].
    Fouchard M; Bichara M; Grüfeld JP; Barbanel C; Meyer P; Funck-Brentano JL
    Nouv Presse Med; 1978 Feb; 7(7):539-43. PubMed ID: 643579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in the renin-angiotensin system in normotensive and hypertensive women during pregnancy and parturition.
    Symonds EM; Broughton Pipkin F; Craven DJ
    Isr J Med Sci; 1976 Jun; 12(6):495-9. PubMed ID: 955863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The renin-angiotensin-aldosterone system in essential arterial hypertension].
    Ruilope L; Alcazar JM; García Robles R; Gutiérrez Millet V; Jarillo MD; Torres J; Morales JM; Rodicio JL
    Rev Clin Esp; 1977 Sep; 146(5):233-7. PubMed ID: 928859
    [No Abstract]   [Full Text] [Related]  

  • 29. Blood pressure effects of acute intravenous renin or oral angiotensin converting enzyme inhibition in essential hypertension.
    Azizi M; Guyene TT; Chatellier G; Ménard J
    J Hypertens; 1994 Apr; 12(4):419-27. PubMed ID: 8064166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of angiotensin converting enzyme inhibitor SQ 14,225 on the blood pressure, renin-angiotensin-aldosterone system and renal function in patients with malignant hypertension (author's transl)].
    Shionoiri H; Uneda S; Tochikubo O; Ohonishi T; Harada J; Sesoko S; Goto E; Fujishima S; Kaneko Y
    Nihon Jinzo Gakkai Shi; 1980 Jan; 22(1):13-22. PubMed ID: 6247528
    [No Abstract]   [Full Text] [Related]  

  • 31. The state and responsiveness of the renin-angiotensin-aldosterone system in patients with type II diabetes mellitus.
    Price DA; De'Oliveira JM; Fisher ND; Williams GH; Hollenberg NK
    Am J Hypertens; 1999 Apr; 12(4 Pt 1):348-55. PubMed ID: 10232494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Exchangeable sodium, total-body potassium, plasma volume, and hypotensive effect of various diuretics in patients with essential hypertension and low plasma renin level (author's transl)].
    Distler A; Keim HJ; Philipp T; Philippi A; Walter U; Werner E
    Dtsch Med Wochenschr; 1974 Apr; 99(17):864-9. PubMed ID: 4834874
    [No Abstract]   [Full Text] [Related]  

  • 33. The renin-angiotensin system and sodium excretion during gestation.
    Symonds EM
    Perspect Nephrol Hypertens; 1976; 5():271-9. PubMed ID: 188010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abnormalities of renal function in essential hypertension with increased circulating levels of insulin-like growth factor I.
    Diez J; Ruilope LM; Rodicio JL
    Arch Mal Coeur Vaiss; 1992 Aug; 85(8):1189-91. PubMed ID: 1482257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Plasma renin activity in essential hypertension with respect to aging, hypertension severity and furosemide test (author's transl)].
    Miyamoto Y
    Nihon Naika Gakkai Zasshi; 1978 Oct; 67(10):1224-33. PubMed ID: 712172
    [No Abstract]   [Full Text] [Related]  

  • 36. [Essential arterial hypertension. Effects of labetalol on blood pressure and renin-angiotensin system (author's transl)].
    Martinand A; Lardoux H; Corvol P; Milliez P
    Nouv Presse Med; 1980 Sep; 9(35):2565-8. PubMed ID: 7001349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies of plasma renin activity in patients with hypertension.
    Kokot F; Kuska J; Czekala Z; Kiecoń I
    Pol Med J; 1968; 7(6):1319-27. PubMed ID: 4305122
    [No Abstract]   [Full Text] [Related]  

  • 38. [Renin-angiotensin-aldosterone system in chronic renal failure. Part 2) change of renin-angiotensin-aldosterone system during hemodialysis (author's transl)].
    Fukuchi S; Nakajima K
    Nihon Jinzo Gakkai Shi; 1977 Oct; 19(10):809-14. PubMed ID: 604580
    [No Abstract]   [Full Text] [Related]  

  • 39. [Blood volume, plasma renin activity and plasma aldosterone concentration in patients with essential hypertension who were treated for more than ten years (author's transl)].
    Nakamura Y
    Nihon Naika Gakkai Zasshi; 1980 Jun; 69(6):714-22. PubMed ID: 6997417
    [No Abstract]   [Full Text] [Related]  

  • 40. [Essential hypertension and the renin-angiotensin-aldosterone system].
    Kokot F
    Kardiol Pol; 1975; 18(3):209-18. PubMed ID: 1142580
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.